Effects of hydroxyurea on T cell count changes during primary HIV infection

AIDS

Volumn 14, Issue 5, 2000, Pages 619-622

  Ravot, Elisabetta ^a,b,c   Tambussi, Giuseppe ^c   Jessen, Heiko ^d   Tinelli, Carmine ^b   Lazzarin, Adriano ^c   Lisziewicz, Julianna ^a,b,c   Lori, Franco ^a,b  

^a Research Institute for Genetic and Human Therapy   (United States)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d Jessen Praxis   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; DELAVIRDINE; DIDANOSINE; HYDROXYUREA; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; RITONAVIR; SAQUINAVIR; STAVUDINE; ZIDOVUDINE;

CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOSTASIS; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; LETTER; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; T LYMPHOCYTE; VIREMIA; VIRUS REPLICATION;

ANTI-HIV AGENTS; CD4-CD8 RATIO; COHORT STUDIES; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HUMANS; HYDROXYUREA; T-LYMPHOCYTES;

EID: 0034085321     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200003310-00021     Document Type: Letter

References (23)